Neuroglee Therapeutics

Singapore, Singapore

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

Sep 2021

Series A

Biotechnology Life Science

Top Investors

EDBIOpenspace CapitalEisaiKuldeep RajputRaman Singh

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Neuroglee Therapeutics

Who are Neuroglee Therapeutics's investors?

Neuroglee Therapeutics's investors include EDBI, Openspace Capital, Eisai, Kuldeep Rajput, Raman Singh.

Where is Neuroglee Therapeutics headquartered?

Neuroglee Therapeutics is headquartered in Singapore, Singapore.

What does Neuroglee Therapeutics do?

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

What stage is Neuroglee Therapeutics at?

Neuroglee Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 9, 2021.

MLA

"Neuroglee Therapeutics — Funding & Investors." VCBacked, September 9, 2021, https://www.vcbacked.co/company/neuroglee-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Neuroglee Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/neuroglee-therapeutics

Wikipedia (cite web)

{{cite web |title=Neuroglee Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuroglee-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 9, 2021.